Triple

T3205347
Position Surface form Disambiguated ID Type / Status
Subject COVID-19 pandemic E67147 entity
Predicate majorVaccineDeveloper P21964 FINISHED
Object Pfizer–BioNTech
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
E335285 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pfizer–BioNTech | Statement: [COVID-19 pandemic, majorVaccineDeveloper, Pfizer–BioNTech]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Pfizer–BioNTech
Context triple: [COVID-19 pandemic, majorVaccineDeveloper, Pfizer–BioNTech]
  • A. BioNTech
    BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
  • B. Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
  • C. Pfizer
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • D. Janssen COVID-19 Vaccine
    The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • E. Janssen Biotech
    Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Pfizer–BioNTech
Triple: [COVID-19 pandemic, majorVaccineDeveloper, Pfizer–BioNTech]
Generated description
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Pfizer–BioNTech
Target entity description: Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
  • A. BioNTech
    BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
  • B. Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
  • C. Pfizer
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • D. Janssen COVID-19 Vaccine
    The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • E. Janssen Biotech
    Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: majorVaccineDeveloper
Context triple: [COVID-19 pandemic, majorVaccineDeveloper, Pfizer–BioNTech]
  • A. majorDeveloper chosen
    Indicates that an entity is a primary or leading developer responsible for creating or significantly contributing to another entity.
  • B. majorTradingCompany
    Indicates that the subject is a principal or highly significant company engaged in large-scale trading activities with the object.
  • C. majorShareholderOf
    Indicates that one entity owns a controlling or significantly large portion of another entity’s shares or equity.
  • D. isMajorCompanyIn
    Indicates that a company is a leading or dominant business entity within a specified country, region, or market.
  • E. memberCompany
    Indicates that a company is formally part of, or affiliated as a member with, a larger organization, group, or association.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ad8589bd988190afa7ed2bdffb7b33 completed March 8, 2026, 2:19 p.m.
NER Named-entity recognition batch_69adaa559848819082d1e61f586278dd completed March 8, 2026, 4:56 p.m.
NED1 Entity disambiguation (via context triple) batch_69b24bcbb0e88190b4413c4ba3de0eeb completed March 12, 2026, 5:14 a.m.
NEDg Description generation batch_69b24ca05434819080ee515b1e7bdcb4 completed March 12, 2026, 5:18 a.m.
NED2 Entity disambiguation (via description) batch_69b24d19250c81908a9c3ac95b83a473 completed March 12, 2026, 5:20 a.m.
PD Predicate disambiguation batch_69ad9e078f7c8190813d9fcb4f5071fb completed March 8, 2026, 4:04 p.m.
Created at: March 8, 2026, 3:07 p.m.